[Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
D000818:Animals; D000970:Antineoplastic Agents; D002746:Chlorpromazine / Q000494:pharmacology*; D003864:Depression, Chemical; D004357:Drug Synergism; D004878:Ergotamine; D007490:Iproniazid / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology*; D011343:Procaine / Q000494:pharmacology*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy*; D012701:Serotonin / Q000627:therapeutic use*; D012702:Serotonin Antagonists; D014191:Tranylcypromine / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology
D000970:Antineoplastic Agents; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D014363:Tryptamines; D012701:Serotonin; D014191:Tranylcypromine; D011343:Procaine; D009020:Morphine; D007490:Iproniazid; D004878:Ergotamine; D002746:Chlorpromazine
Vliianie antagonistov serotonina i ingibitorov monoaminoksidazy na protivoopukholevoe deĭstvie serotonina.